Site Home   Gender and Cardiovascular Disease       Introduction to Gender and Health   The Gender Lens Tool

Diabetes

Aggressive risk factor modification, especially hypertension and lipids. (quality of evidence II, Grade B recommendation)

 [1][10]Women with gestational diabetes should be monitored over the long-term. (consensus, quality of evidence III, Grade C recommendation)[1][10]

The Canadian Diabetes Association 2003 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada are available on the CDA website and includes sections on the assessment and management of hypertension and dyslipidemia. The hypertension section goes into detail and reviews the evidence for the target BP of 130/80.  The section on dyslipidemia also goes into detail and includes evidence-based guidelines for cholesterol evaluation and management. Read more about why most people with diabetes are considered to be high risk for vascular events and should have a target level LDL-C (low-density lipoprotein cholesterol) <2.5 mmol/L and a TC:HDL-C (total cholesterol: high-density lipoprotein cholesterol) ratio of < 4 mmol/L and consult the guidelines.[11]

_________________________________

1. Amberson, B.L., (2000) Risk Factors and Primary Prevention of Ischemic Heart Disease in Women. Canadian Cardiovascular Society Consensus Conference: Women and Ischemic Heart Disease, October 2000: 4/1-4/25.

10. Mosca L, et al. Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women. AHA/ACC 2004 Scientific Statement. Circulation 2004;109:672-693.

11. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2003 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada. Can J Diabetes. 2003;27(suppl 2).

All references for this section